Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxalate ion is a small, planar dianion with the formula C₂O₄²⁻, produced by the deprotonation of oxalic acid. It is found as a normal metabolite in plants and animals and acts as a bidentate ligand in coordination chemistry. Oxalate is not itself a therapeutic target but can play a secondary role in human health, particularly in relation to kidney stone formation (calcium oxalate stones) and rare metabolic disorders such as primary hyperoxaluria. Free oxalate is typically measured in urine or plasma as a biomarker of stone risk or metabolic disturbance rather than as a molecular target for drugs or biologics. Because "Free oxalate" is not a canonical molecular target (such as a receptor, enzyme, ion channel, etc.), its designation as a target is considered incorrect for typical drug discovery contexts.
Not a direct drug target with mechanisms akin to inhibition or activation. Chelation (as with calcium—drugs or dietary measures that bind oxalate limit its absorption).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxalate ion.